SAN FRANCISCO, Dec. 13, 2010 /PRNewswire/ — iLeverage (www.ilvrge.com), a leading patent
broker, today announced the successful closing of the Biocontrol
patent portfolio sale.
The patents were offered to companies that participate in the
relevant markets as well as to a number of IP licensing companies.
After announcing the auction date on Tuesday Dec. 7,
iLeverage received several offers; the most compelling came from
the licensing companies.
“We met with leaders of the medical monitoring market in the USA
and in Europe with the hope that an operating company would acquire
the patents, however due to the wide coverage of this portfolio and
its relatedness to so many different companies, the patents were
given the highest values by licensing companies – a natural
result from an economic standpoint,” said Uzi Aloush, iLeverage’s
CEO. For more information, please see www.ilvrge.com.
RELATED LINKS
‘/>”/>
